BCEL
Atreca, Inc. Class A Common Stock
BCEL
BCEL
Delisted
BCEL was delisted on the 18th of March, 2024.
54 hedge funds and large institutions have $16.3M invested in Atreca, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-5
Holders Change %
-8.47%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
10
Reduced
10
Closed
7
Calls
$40K
Puts
$6K
Net Calls
+$34K
Net Calls Change
-$53K
Top Buyers
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$454K |
| 2 |
Goldman Sachs
New York
|
+$39.9K |
| 3 |
Charles Schwab
San Francisco,
California
|
+$26.2K |
| 4 |
Renaissance Technologies
New York
|
+$16K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$12.5K |
Top Sellers
| 1 |
GF
Gates Foundation
Seattle,
Washington
|
-$227K |
| 2 |
Millennium Management
New York
|
-$167K |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$153K |
| 4 |
BlackRock
New York
|
-$95.6K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$33.5K |
